Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, today announced that it has received approval of clinical trial application (CTA) from the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) and The Health and Disability Ethics Committees (HDEC) to initiate...
Datasea Pre-Announces Full-Year Fiscal 2025 Revenue of $90 Million, Representing a Year-Over-Year Increase of 275%, with Expected Significant Gross Profit Improvement
BEIJING, Nov. 19, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a Nevada-registered digital technology company focused on innovations in acoustic high-tech and 5G AI multimodal digital technologies, today pre-announced that its revenue for the fiscal year ending June 30, 2025, is expected to be approximately $90.0 million....
Xiao-I Corporation Announces Strategic Cooperation with Deafopia to Expand Market Outreach for AI Hardware Business
SHANGHAI, Nov. 19, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a leading artificial intelligence company ("Xiao-I") , today announced a strategic cooperation with Deafopia, a nonprofit organization dedicated to supporting businesses within the deaf and hard-of-hearing communities. This collaboration will enhance the market visibility and distribution of Xiao-I's newly developed AI hardwares, with Deafopia managing outreach and expanding distribution...
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to accelerate biomarker discovery and improve our understanding of Parkinson's disease (PD). This collaboration aims to address the critical need...
Say Hello to 3.0: Datarithm Releases Latest Version of Inventory Management Solution
SYRACUSE, N.Y., Nov. 19, 2024 /PRNewswire/ -- In a landscape marked by intense competition, rising costs, and stringent regulatory requirements, independent pharmacies face an array of challenges that threaten their viability and success. Today, Datarithm® is proud to announce a solution to these challenges with the latest release of its proprietary inventory management solution. Datarithm Version 3.0 represents a...
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS
NANTONG and SUZHOU, China, Nov. 19, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to RAG-21, its novel siRNA therapy targeting the FUS gene, for the treatment of amyotrophic lateral sclerosis (ALS). RAG-21 is an siRNA therapy...
Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity
"DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes. Participants can use a continuous glucose monitoring (CGM) device and the Health2Sync mobile app to track their food intake and physical activity, learning how dietary and exercise...
Hankyung.com introduces: Unmissable BFCM Deal on Amazon: Get EXTREME DUAL ARGININE PLUS, Free Shipping, and Subscribe & Save Options!
https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.jpgPhoto: 1,000mg x 120 Tablets, 2 Months Supply, Boost up Energy & Vitality for Men's Sports Performance SEOUL, South Korea, Nov. 19, 2024 /PRNewswire/ -- This Black Friday and Cyber Monday (BFCM) season, health and fitness enthusiasts can enjoy exclusive savings on EXTREME DUAL ARGININE PLUS, the premium supplement designed to boost workout performance and support overall wellness. Available...
TRACE International Releases the 2024 Bribery Risk Matrix
ANNAPOLIS, Md., Nov. 19, 2024 /PRNewswire/ -- TRACE, a non-profit international business association dedicated to anti-bribery, compliance, and good governance, has released the 2024 Bribery Risk Matrix, measuring business bribery risk in 194 jurisdictions. Originally published in 2014 to meet a need in the business community for more reliable information about bribery risk worldwide, the TRACE Matrix helps companies examine...
2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries
AMSTERDAM, Nov. 19, 2024 /PRNewswire/ -- The 2024 Access to Medicine Index finds that pharmaceutical companies are not fully leveraging their potential to expand access in underserved regions. While the Foundation's new analysis shows improvement by some pharmaceutical companies in distinct areas, overall, momentum has slowed since the 2022 Index that overlapped with the COVID-19 pandemic, and growing gaps...
